Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracorporeal Membrane Oxygenation | 5 | 2025 | 682 | 1.750 |
Why?
|
| Shock, Septic | 2 | 2021 | 148 | 1.130 |
Why?
|
| Sepsis | 3 | 2015 | 494 | 0.990 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2019 | 493 | 0.790 |
Why?
|
| Respiratory Insufficiency | 1 | 2025 | 240 | 0.780 |
Why?
|
| Hospitals, Pediatric | 3 | 2015 | 802 | 0.700 |
Why?
|
| Shock | 1 | 2021 | 94 | 0.630 |
Why?
|
| von Willebrand Diseases | 1 | 2019 | 55 | 0.580 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2019 | 324 | 0.480 |
Why?
|
| International Classification of Diseases | 1 | 2015 | 98 | 0.430 |
Why?
|
| Renal Replacement Therapy | 1 | 2015 | 163 | 0.410 |
Why?
|
| Infant | 7 | 2025 | 13281 | 0.300 |
Why?
|
| Hemorrhage | 2 | 2024 | 492 | 0.280 |
Why?
|
| Child, Preschool | 6 | 2025 | 14985 | 0.270 |
Why?
|
| Infant, Newborn | 5 | 2024 | 8526 | 0.240 |
Why?
|
| Child | 7 | 2025 | 26162 | 0.230 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17633 | 0.230 |
Why?
|
| Literacy | 1 | 2024 | 14 | 0.220 |
Why?
|
| Adolescent | 5 | 2025 | 20734 | 0.210 |
Why?
|
| Propensity Score | 1 | 2025 | 266 | 0.210 |
Why?
|
| Reading | 1 | 2024 | 75 | 0.210 |
Why?
|
| Survivors | 1 | 2025 | 345 | 0.200 |
Why?
|
| Nervous System Diseases | 1 | 2024 | 396 | 0.160 |
Why?
|
| Inpatients | 1 | 2024 | 549 | 0.160 |
Why?
|
| Comorbidity | 2 | 2015 | 1587 | 0.160 |
Why?
|
| Coagulants | 1 | 2019 | 8 | 0.160 |
Why?
|
| Factor VIII | 1 | 2019 | 51 | 0.150 |
Why?
|
| Shock, Cardiogenic | 1 | 2021 | 172 | 0.150 |
Why?
|
| OX40 Ligand | 1 | 2019 | 9 | 0.150 |
Why?
|
| Caregivers | 1 | 2024 | 572 | 0.140 |
Why?
|
| Glomerulonephritis | 1 | 2019 | 75 | 0.140 |
Why?
|
| Male | 8 | 2025 | 64506 | 0.140 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3407 | 0.140 |
Why?
|
| Female | 7 | 2025 | 70349 | 0.130 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 233 | 0.130 |
Why?
|
| Humans | 9 | 2025 | 130444 | 0.120 |
Why?
|
| Syndrome | 1 | 2019 | 1160 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2019 | 498 | 0.120 |
Why?
|
| Length of Stay | 1 | 2021 | 1393 | 0.110 |
Why?
|
| Peptide Fragments | 1 | 2019 | 687 | 0.110 |
Why?
|
| Macrophages | 1 | 2019 | 655 | 0.110 |
Why?
|
| Organ Dysfunction Scores | 1 | 2014 | 53 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2019 | 1451 | 0.110 |
Why?
|
| Multiple Organ Failure | 1 | 2015 | 144 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 982 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2025 | 12853 | 0.100 |
Why?
|
| Heart Defects, Congenital | 1 | 2024 | 1878 | 0.090 |
Why?
|
| Databases, Factual | 1 | 2015 | 1222 | 0.080 |
Why?
|
| United States | 2 | 2015 | 11828 | 0.070 |
Why?
|
| Age Factors | 1 | 2014 | 2836 | 0.070 |
Why?
|
| Prevalence | 1 | 2014 | 2683 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 2096 | 0.040 |
Why?
|
| Young Adult | 1 | 2015 | 9975 | 0.040 |
Why?
|
| Receptors, OX40 | 1 | 2019 | 9 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2019 | 545 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2024 | 3030 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2024 | 6445 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 4700 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 18203 | 0.010 |
Why?
|
| Animals | 1 | 2019 | 33909 | 0.010 |
Why?
|